Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study June 24, 2022 at 8:00 AM EDT Click Here for Webcast Supporting Materials NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial – June 24, 2022 1 MB
NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial – June 24, 2022 1 MB